Prevention of viral infections after bone marrow transplantation.
After bone marrow transplantation, a number of viral infections contribute to the morbidity and mortality of the procedure. Established preventive measures to avoid primary infection and reactivation of herpes-and cytomegaloviruses are outlined. Possible future strategies against these viruses (e. g., monoclonal antibodies, transfer of T-lymphocytes) and the possible role of improved diagnostic tools are briefly discussed.
Schuler
U
U
Medizinische Klinik, Universität Tübingen, Federal Republic of Germany.
Ehninger
G
G
D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000627:therapeutic use; D006561:Herpes Simplex / Q000517:prevention & control*; D006562:Herpes Zoster / Q000517:prevention & control*; D006801:Humans; D007116:Immunization, Passive
D015774:Ganciclovir